高甘油三酯血症性急性胰腺炎诊治急诊专家共识

2021-08-11 中国全科医学

脂蛋白代谢异常导致的血清甘油三酯水平显著升高是诱发急性胰腺炎的第二大原因,而高甘油三酯血症所致急性胰腺炎称为高甘油三酯血症性急性胰腺炎。高甘油三酯血症性急性胰腺炎的病因隐匿,易被误诊,同时由于其病因有

中文标题:

高甘油三酯血症性急性胰腺炎诊治急诊专家共识

发布机构:

发布日期:

2021-08-11

简要介绍:

脂蛋白代谢异常导致的血清甘油三酯水平显著升高是诱发急性胰腺炎的第二大原因,而高甘油三酯血症所致急性胰腺炎称为高甘油三酯血症性急性胰腺炎。高甘油三酯血症性急性胰腺炎的病因隐匿,易被误诊,同时由于其病因有别于胆源性急性胰腺炎及酒精性急性胰腺炎等,因此其针对性诊断、治疗方法与其他类型急性胰腺炎有所不同。《高甘油三酯血症性急性胰腺炎诊治急诊专家共识》专家组针对高甘油三酯血症性急性胰腺炎的病因、发病机制、临床特征、诊断、严重程度分级与评估、治疗(包括病因治疗、常规治疗等)等进行了归纳、总结,以期为该病的诊治问题提供行之有效的解决方案。 
 

相关资料下载:
[AttachmentFileName(sort=1, fileName=高甘油三酯血症性急性胰腺炎诊治急诊专家共识_宏欣.pdf)] GetToolGuiderByIdResponse(projectId=1, id=604d31c002168e70, title=高甘油三酯血症性急性胰腺炎诊治急诊专家共识, enTitle=, guiderFrom=中国全科医学, authorId=0, author=, summary=脂蛋白代谢异常导致的血清甘油三酯水平显著升高是诱发急性胰腺炎的第二大原因,而高甘油三酯血症所致急性胰腺炎称为高甘油三酯血症性急性胰腺炎。高甘油三酯血症性急性胰腺炎的病因隐匿,易被误诊,同时由于其病因有, cover=https://img.medsci.cn/2021831/1630424527646_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed Aug 11 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="row"><span id="ChDivSummary" class="abstract-text" style="color: #666666;">脂蛋白代谢异常导致的血清甘油三酯水平显著升高是诱发急性胰腺炎的第二大原因,而高甘油三酯血症所致急性胰腺炎称为高甘油三酯血症性急性胰腺炎。高甘油三酯血症性急性胰腺炎的病因隐匿,易被误诊,同时由于其病因有别于胆源性急性胰腺炎及酒精性急性胰腺炎等,因此其针对性诊断、治疗方法与其他类型急性胰腺炎有所不同。《高甘油三酯血症性急性胰腺炎诊治急诊专家共识》专家组针对高甘油三酯血症性急性胰腺炎的病因、发病机制、临床特征、诊断、严重程度分级与评估、治疗(包括病因治疗、常规治疗等)等进行了归纳、总结,以期为该病的诊治问题提供行之有效的解决方案。&nbsp;</span></div> <div class="row">&nbsp;</div>, tagList=[TagDto(tagId=322, tagName=急性胰腺炎)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=322, guiderKeyword=急性胰腺炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8735, appHits=644, showAppHits=0, pcHits=995, showPcHits=8088, likes=3, shares=79, comments=21, approvalStatus=1, publishedTime=Tue Aug 31 23:53:41 CST 2021, publishedTimeString=2021-08-11, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Tue Aug 31 23:42:15 CST 2021, updatedBy=6415643, updatedName=凯晨, updatedTime=Sat Jan 06 07:07:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=高甘油三酯血症性急性胰腺炎诊治急诊专家共识_宏欣.pdf)])
高甘油三酯血症性急性胰腺炎诊治急诊专家共识_宏欣.pdf
下载请点击:
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2097880, encodeId=97cb209e880a4, content=学习了,规范诊疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b70c8402753, createdName=ms9000000997595824, createdTime=Tue Nov 01 17:03:20 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192236, encodeId=31ff1192236e2, content=学习,学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd224796134, createdName=14388fadm33暂无昵称, createdTime=Fri Feb 11 11:00:20 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189829, encodeId=6dd3118982926, content=还有么, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d585243593, createdName=光明骑士, createdTime=Thu Feb 03 06:44:29 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178897, encodeId=1ffd11e889705, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/3dac6c023a2227430f582458b92baf75.jpg, createdBy=a0242124870, createdName=1881fb789am, createdTime=Thu Dec 30 16:22:00 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071751, encodeId=e54c10e1751a8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe15705834, createdName=ms4000001809038213, createdTime=Fri Nov 19 13:57:42 CST 2021, time=2021-11-19, status=1, ipAttribution=)]
    2022-11-01 ms9000000997595824

    学习了,规范诊疗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2097880, encodeId=97cb209e880a4, content=学习了,规范诊疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b70c8402753, createdName=ms9000000997595824, createdTime=Tue Nov 01 17:03:20 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192236, encodeId=31ff1192236e2, content=学习,学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd224796134, createdName=14388fadm33暂无昵称, createdTime=Fri Feb 11 11:00:20 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189829, encodeId=6dd3118982926, content=还有么, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d585243593, createdName=光明骑士, createdTime=Thu Feb 03 06:44:29 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178897, encodeId=1ffd11e889705, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/3dac6c023a2227430f582458b92baf75.jpg, createdBy=a0242124870, createdName=1881fb789am, createdTime=Thu Dec 30 16:22:00 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071751, encodeId=e54c10e1751a8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe15705834, createdName=ms4000001809038213, createdTime=Fri Nov 19 13:57:42 CST 2021, time=2021-11-19, status=1, ipAttribution=)]
    2022-02-11 14388fadm33暂无昵称

    学习,学习!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2097880, encodeId=97cb209e880a4, content=学习了,规范诊疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b70c8402753, createdName=ms9000000997595824, createdTime=Tue Nov 01 17:03:20 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192236, encodeId=31ff1192236e2, content=学习,学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd224796134, createdName=14388fadm33暂无昵称, createdTime=Fri Feb 11 11:00:20 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189829, encodeId=6dd3118982926, content=还有么, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d585243593, createdName=光明骑士, createdTime=Thu Feb 03 06:44:29 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178897, encodeId=1ffd11e889705, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/3dac6c023a2227430f582458b92baf75.jpg, createdBy=a0242124870, createdName=1881fb789am, createdTime=Thu Dec 30 16:22:00 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071751, encodeId=e54c10e1751a8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe15705834, createdName=ms4000001809038213, createdTime=Fri Nov 19 13:57:42 CST 2021, time=2021-11-19, status=1, ipAttribution=)]
    2022-02-03 光明骑士

    还有么

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2097880, encodeId=97cb209e880a4, content=学习了,规范诊疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b70c8402753, createdName=ms9000000997595824, createdTime=Tue Nov 01 17:03:20 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192236, encodeId=31ff1192236e2, content=学习,学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd224796134, createdName=14388fadm33暂无昵称, createdTime=Fri Feb 11 11:00:20 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189829, encodeId=6dd3118982926, content=还有么, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d585243593, createdName=光明骑士, createdTime=Thu Feb 03 06:44:29 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178897, encodeId=1ffd11e889705, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/3dac6c023a2227430f582458b92baf75.jpg, createdBy=a0242124870, createdName=1881fb789am, createdTime=Thu Dec 30 16:22:00 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071751, encodeId=e54c10e1751a8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe15705834, createdName=ms4000001809038213, createdTime=Fri Nov 19 13:57:42 CST 2021, time=2021-11-19, status=1, ipAttribution=)]
    2021-12-30 1881fb789am

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2097880, encodeId=97cb209e880a4, content=学习了,规范诊疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b70c8402753, createdName=ms9000000997595824, createdTime=Tue Nov 01 17:03:20 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192236, encodeId=31ff1192236e2, content=学习,学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd224796134, createdName=14388fadm33暂无昵称, createdTime=Fri Feb 11 11:00:20 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189829, encodeId=6dd3118982926, content=还有么, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4d585243593, createdName=光明骑士, createdTime=Thu Feb 03 06:44:29 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178897, encodeId=1ffd11e889705, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/19/3dac6c023a2227430f582458b92baf75.jpg, createdBy=a0242124870, createdName=1881fb789am, createdTime=Thu Dec 30 16:22:00 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071751, encodeId=e54c10e1751a8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe15705834, createdName=ms4000001809038213, createdTime=Fri Nov 19 13:57:42 CST 2021, time=2021-11-19, status=1, ipAttribution=)]
    2021-11-19 ms4000001809038213

    学习了

    0